Medication info
Innoen Abelton 150 mg Tablets (Irbesartan)

Innoen Abelton 150 mg Tablets (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
HK Innoen Co., Ltd.
Appearance
White or almost white, oval, biconvex film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200808562 · Notified 2008.08.08 · Insurance code 640005840

Summary

Main use
Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. Essential hypertension Adults: Administer irbesartan orally at 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily, but 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients on hemodialysis, or in older adults aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be administered concomitantly. The effect is increased particularly when used with a low dose of a diuretic (e.g., hydrochlorothiazide). Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be administered concomitantly to achieve the target blood pressure. Older adults Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered in older adults aged 75 years and older. Patients with renal impairment Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered in patients on hemodialysis. Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
HK Innoen Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension in patients with essential hypertension. It effectively protects kidney function in patients with type 2 diabetes who have accompanying kidney disease and assists in treatment. Therefore, it is a drug that contributes to stabilizing blood pressure and preventing kidney complications.

How to take

Adult dose

This medicine may be taken with or without food. Essential hypertension Adults: Administer irbesartan orally at 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily, but 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients on hemodialysis, or in older adults aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be administered concomitantly. The effect is increased particularly when used with a low dose of a diuretic (e.g., hydrochlorothiazide). Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be administered concomitantly to achieve the target blood pressure. Older adults Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered in older adults aged 75 years and older. Patients with renal impairment Dose adjustment is generally not necessary, but an initial dose of 75 mg should be considered in patients on hemodialysis. Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in pregnant or possibly pregnant women, nursing mothers, patients with severe liver impairment, and patients with certain genetic diseases. Cautious use is required for elderly patients and those with hyperkalemia, liver impairment, and heart and kidney disease, with regular monitoring of blood pressure, kidney function, and electrolyte levels. During treatment, side effects such as dizziness, fatigue, headache, indigestion, and rash may occur, and in rare cases, angioedema or severe allergic reactions may arise, requiring caution. Due to the blood pressure-lowering effects, symptoms such as hypotension, shock, and loss of consciousness may occur, requiring close observation of the patient's condition. Patients with kidney disease should be especially cautious due to the risk of worsening kidney function, and treatment should be stopped if liver function abnormalities occur. This medication can increase serum potassium levels, so it should be avoided in combination with potassium supplements or potassium-sparing diuretics, and potassium levels should be monitored regularly. When used with other antihypertensives, blood pressure reduction may be enhanced, and consultation with a healthcare provider is necessary before taking it. Patients may experience dizziness or fatigue when driving or operating machinery, requiring caution. Patients undergoing diabetes treatment or at risk of hypoglycemia should consult with a doctor and check their blood glucose levels before taking this medication. In case of overdose, symptoms such as hypotension, tachycardia, and bradycardia may occur, necessitating immediate medical assistance. It is safe to store this medication out of reach of children and not to transfer it to another container.

Side effects

  • Respiratory infection
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea/vomiting
  • musculoskeletal injury
  • chest pain
Show 102 more
  • dyspepsia/heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety/nervousness
  • upper urinary tract infection
  • fever
  • chills
  • facial swelling
  • arm swelling
  • flushing
  • hypertension
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia/conduction abnormality
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal bloating
  • limb swelling
  • muscle stiffness
  • arthritis
  • myalgia
  • chest pain
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • somnolence
  • mood disorders
  • depression
  • sensory abnormalities
  • tremor
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • nasal hemorrhage
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual disturbances
  • auditory abnormalities
  • ear infection
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • elevated plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reaction
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • diarrhea
  • dyspepsia
  • nausea
  • tinnitus
  • myalgia
  • elevated plasma creatine kinase
  • arthralgia
  • tachycardia
  • hepatitis
  • liver function abnormalities
  • renal failure
  • kidney damage
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • hypoglycemia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and kept in a cool, dry place below 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer time.

Appearance and packaging

Appearance

White or almost white, oval, biconvex film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.